AI coach could help fibromyalgia patients exercise at home
NCT ID NCT07674485
First seen Jun 29, 2026 · Last updated Jul 02, 2026 · Updated 3 times
Summary
This study tests whether an artificial intelligence (AI) and computer vision system can help people with fibromyalgia perform effective exercise at home. Participants use a smartphone or tablet app that watches their movements and gives real-time feedback, with or without added resistance training. The goal is to see if this technology can reduce the overall impact of fibromyalgia and improve physical function, offering a more accessible alternative to in-person rehabilitation.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Artificial intelligence- and computer vision-assisted telerehabilitation (Rehbody platform) with or without resistance training
- What this could lead to
- If effective, this AI-driven home exercise program could offer a convenient, accessible way for people with fibromyalgia to reduce disease impact and improve physical function without needing frequent clinic visits.
- What could go wrong
- This is a relatively small, early-stage trial (66 participants) testing a new technology platform. The AI feedback may not work as well for everyone, and benefits seen here might not apply to broader populations or different healthcare settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 66 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2027
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 years or older, of any sex/gender, with a documented medical diagnosis of fibromyalgia established in primary or secondary healthcare settings according to the American College of Rheumatology (ACR) criteria (Häuser \& Fitzcharles, 2018). * Individuals able to understand and complete the self-report questionnaires used in the study. * Individuals with access to a compatible electronic device (smartphone, tablet, or computer) and an internet connection required for participation in the telerehabilitation intervention. * Individuals with basic digital literacy skills, defined as the ability to use electronic devices and interact with commonly used applications. * Individuals who provide written informed consent to participate in the study. Exclusion Criteria: * Current participation in another structured therapeutic exercise program, whether supervised or unsupervised. * Moderate to severe functional dependence in activities of daily living, defined as a score \<60 on the Barthel Index. * Absolute contraindications to therapeutic exercise, including hypertensive crisis (≥170/110 mmHg), dyspnea at rest, resting tachycardia, or severe glycemic abnormalities (blood glucose \>250 mg/dL or \<90 mg/dL in individuals receiving insulin therapy). * Severe uncontrolled pain, defined as a score ≥8 on the Numeric Pain Rating Scale (NPRS) at rest. * Medical or neurological conditions that significantly limit the safe performance of physical exercise, as determined by clinical assessment. * Recent changes in fibromyalgia-specific pharmacological treatment within the previous 4 weeks, to ensure clinical stability throughout the intervention period.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fibromyalgia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a light bulb dial down chronic pain?
- Can a Hands-On nerve technique ease Fibromyalgia's grip?
- Why some days hurt more: charting Fibromyalgia's daily swings
- Zapping the vagus nerve: a new hope for fibromyalgia pain?
- Can a Video-Call stretching program ease fibromyalgia pain?
- Can a blood pressure drug rewrite trauma memories to ease fibromyalgia?